BioInvent International AB (publ) 0H22.IL Stock
BioInvent International AB (publ) Price Chart
BioInvent International AB (publ) 0H22.IL Financial and Trading Overview
| BioInvent International AB (publ) stock price | 18.22 SEK |
| Previous Close | 20.15 SEK |
| Open | 0 SEK |
| Bid | 18.7 SEK x N/A |
| Ask | 20.65 SEK x N/A |
| Day's Range | 20.3 - 20.3 SEK |
| 52 Week Range | 19.08 - 48.58 SEK |
| Volume | 25.24K SEK |
| Avg. Volume | 37 SEK |
| Market Cap | 1.34B SEK |
| Beta (5Y Monthly) | 0.292069 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -5.01 SEK |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
0H22.IL Valuation Measures
| Enterprise Value | 283.19M SEK |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 4.1011963 |
| Price/Book (mrq) | 0.8541973 |
| Enterprise Value/Revenue | 0.869 |
| Enterprise Value/EBITDA | -5.227 |
Trading Information
BioInvent International AB (publ) Stock Price History
| Beta (5Y Monthly) | 0.292069 |
| 52-Week Change | -52.91% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 48.58 SEK |
| 52 Week Low | 19.08 SEK |
| 50-Day Moving Average | 27.01 SEK |
| 200-Day Moving Average | 35.23 SEK |
0H22.IL Share Statistics
| Avg. Volume (3 month) | 37 SEK |
| Avg. Daily Volume (10-Days) | 74 SEK |
| Shares Outstanding | 65.8M |
| Float | 34.21M |
| Short Ratio | N/A |
| % Held by Insiders | 11.09% |
| % Held by Institutions | 55.14% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1:25 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | -14.88% |
| Operating Margin (ttm) | -19.38% |
| Gross Margin | 100.00% |
| EBITDA Margin | -16.63% |
Management Effectiveness
| Return on Assets (ttm) | -2.59% |
| Return on Equity (ttm) | -3.38% |
Income Statement
| Revenue (ttm) | 325.72M SEK |
| Revenue Per Share (ttm) | 5.14 SEK |
| Quarterly Revenue Growth (yoy) | -2.50% |
| Gross Profit (ttm) | 326.13M SEK |
| EBITDA | -54181000 SEK |
| Net Income Avi to Common (ttm) | -48487000 SEK |
| Diluted EPS (ttm) | -0.61 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 1.02B SEK |
| Total Cash Per Share (mrq) | 15.48 SEK |
| Total Debt (mrq) | 25.05M SEK |
| Total Debt/Equity (mrq) | 1.6 SEK |
| Current Ratio (mrq) | 14.222 |
| Book Value Per Share (mrq) | 23.765 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -40355000 SEK |
| Levered Free Cash Flow (ttm) | -29663250 SEK |
Profile of BioInvent International AB (publ)
| Country | United Kingdom |
| State | N/A |
| City | Lund |
| Address | The Gamma Building |
| ZIP | 223 70 |
| Phone | 46 4 62 86 85 50 |
| Website | https://www.bioinvent.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 102 |
BioInvent International AB (publ), a clinical-stage company, discovers, researches, and develops immuno-modulatory antibodies for the treatment of cancer in Sweden, Europe, the United States, and internationally. Its drug candidate is BI-1206 for the treatment of non-Hodgkin lymphoma and solid tumors. The company also develops tumor associated myeloid cells; cancer-associated regulatory T cells, which modulate the immune system; BT-001 for solid tumors; and BI-1808 and BI-1910, which are anti-TNFR2 antibodies for the treatment of solid tumors and cutaneous T-cell lymphoma. It has a partnership and collaboration with Transgene to co-develop BT-001 multi-functional oncolytic viruses for treatment of solid tumors; and collaboration and supply agreement with Merck to evaluate BT-001 in combination with Keytruda, and in BI-1808. BioInvent International AB (publ) was incorporated in 1996 and is based in Lund, Sweden.
Q&A For BioInvent International AB (publ) Stock
What is a current 0H22.IL stock price?
BioInvent International AB (publ) 0H22.IL stock price today per share is 18.22 SEK.
How to purchase BioInvent International AB (publ) stock?
You can buy 0H22.IL shares on the IOB exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for BioInvent International AB (publ)?
The stock symbol or ticker of BioInvent International AB (publ) is 0H22.IL.
Which industry does the BioInvent International AB (publ) company belong to?
The BioInvent International AB (publ) industry is Biotechnology.
How many shares does BioInvent International AB (publ) have in circulation?
The max supply of BioInvent International AB (publ) shares is 70.36M.
What is BioInvent International AB (publ) Price to Earnings Ratio (PE Ratio)?
BioInvent International AB (publ) PE Ratio is now.
What was BioInvent International AB (publ) earnings per share over the trailing 12 months (TTM)?
BioInvent International AB (publ) EPS is -5.01 SEK over the trailing 12 months.
Which sector does the BioInvent International AB (publ) company belong to?
The BioInvent International AB (publ) sector is Healthcare.